| For: | Li YP, Liu CR, He L, Dang SS. Hepatitis B cure: Current situation and prospects. World J Hepatol 2024; 16(6): 900-911 [PMID: 38948438 DOI: 10.4254/wjh.v16.i6.900] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i6/900.htm |
| Number | Citing Articles |
| 1 |
Soe Thiha Maung, Roongruedee Chaiteerakij. Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B. Journal of Viral Hepatitis 2025; 32(7) doi: 10.1111/jvh.70040
|
| 2 |
Li-li Liu, Yi Feng, Chao-yi Ren, Yi Liu, Ming-hui Zhu, Guo-xiang Hao, Tian-tian Gao. A Real-World Pharmacological Assessment of Tenofovir Amibufenamide and Tenofovir Alafenamide in 48-Week Chronic Hepatitis B Treatment: Efficacy, Safety, and Cost-Effectiveness. Current Medical Science 2025; doi: 10.1007/s11596-025-00120-5
|
